跳至主要内容
临床试验/IRCT20210427051098N6
IRCT20210427051098N6尚未招募Unknown

The effects of berberis integerrima extract on liver enzymes, liver steatosis and fibrosis in patients with non-alcoholic fatty liver disease (NAFLD) following the DASH diet: a double-blind randomized clinical trial.

Yazd University of Medical Sciences0 个研究点目标入组 60 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age 18 and older
  • Diagnosis of the disease by ultrasound with a standard method
  • ALT >30 IU/L in men and ALT >19 IU/L in women
  • BMI higher than 18.5 and less than 30

排除标准

  • Taking corticosteroids
  • Pregnancy and breastfeeding
  • Alcohol consumption (men: ethanol > 140 g per week, women: ethanol > 70 g per week)
  • History of diseases including liver cirrhosis, viral hepatitis, cardiovascular diseases, cancer
  • Medication history including corticosteroids, non-steroidal anti-inflammatory drugs, drugs affecting blood sugar, lipid profile, body weight and liver function.
  • Disease relapse and patient hospitalization
  • Barberry allergy

研究者

发起方
Yazd University of Medical Sciences

相似试验

The effects of berberis integerrima extract on the... | 临床试验